Skip to main content
Clinical Trials/JPRN-UMIN000036647
JPRN-UMIN000036647
Recruiting
未知

tility of a novel estimation method for hemoglobin A1c using glycated albumin in type 2 diabetes mellitus patients with end-stage renal disease - Utility of a novel estimation method for hemoglobin A1c using glycated albumin in type 2 diabetes mellitus patients with end-stage renal disease

Osafune Clinic0 sites100 target enrollmentMay 5, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 diabetes mellitus patients with end-stage renal disease
Sponsor
Osafune Clinic
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 5, 2019
End Date
December 31, 2020
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Osafune Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Type 1 diabetes patients Patients having severe infections, before and after operation and trauma Pregnancy Patient who are inadequate to enter this study due to the other reasons by physicians judgments

Outcomes

Primary Outcomes

Not specified

Similar Trials